The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000441.2(SLC26A4):c.2145G>T (p.Lys715Asn)

CA261425

43541 (ClinVar)

Gene: SLC26A4
Condition: Pendred syndrome
Inheritance Mode: Autosomal recessive inheritance
UUID: b6f4c008-3e27-485a-bddb-183a7f974693

HGVS expressions

NM_000441.2:c.2145G>T
NM_000441.2(SLC26A4):c.2145G>T (p.Lys715Asn)
NC_000007.14:g.107710109G>T
CM000669.2:g.107710109G>T
NC_000007.13:g.107350554G>T
CM000669.1:g.107350554G>T
NC_000007.12:g.107137790G>T
NG_008489.1:g.54475G>T
ENST00000644269.2:c.2145G>T
ENST00000644846.1:c.801G>T
ENST00000265715.7:c.2145G>T
ENST00000492030.2:n.377-46G>T
NM_000441.1:c.2145G>T

Likely Pathogenic

Met criteria codes 3
PM3_Strong PS3_Supporting PP4
Not Met criteria codes 2
BS1 BP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Hearing Loss Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for CDH23, COCH, GJB2, KCNQ4, MYO6, MYO7A, SLC26A4, TECTA and USH2A Version 2

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Hearing Loss VCEP
The c.2145G>T variant in SLC26A4 is a missense variant predicted to cause substitution of lysine by asparagine at amino acid 715 (p.Lys715Asn). The highest population minor allele frequency in gnomAD v2.1.1 is 0.06777% (95% CI of 29/30610) in the South Asian population (PM2_supporting, BS1, and BA1 not met). This variant has been observed in 3 probands with hearing loss in trans with another pathogenic or likely pathogenic variant (PM3_Strong; PMID: 26969326, PMID: 32417962, LMM unpublished data SCV000060131.6). At least one proband with this variant presented with clinical features of sensorineural hearing loss and enlarged vestibular aqueduct, a phenotype specific for Pendred syndrome (PP4; LMM unpublished data SCV000060131.6).This variant has been observed in several other cases where a second variant in SLC26A4 was not found (PMID: 19509082, 19287372, 26188157, 32417962). Functional studies including fluorescence assays and chloride exchange experiments have demonstrated that this variant impacts protein function (PS3_Supporting; PMID: 19509082). Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, this variant is classified as likely pathogenic for autosomal recessive Pendred syndrome. ACMG/AMP Criteria applied as specified by the Hearing Loss Expert Panel 08/22/23: PM3_Strong, PS3_Supporting, PP4.
Met criteria codes
PM3_Strong
LMM internal data: 2yo female with congenital sensorineural hearing loss and EVA. Heterozygous. Also het. for p.Thr410Met, classified as P by VCEP (0.5 PM3 points)
PS3_Supporting
Fluorescence assay performed by Dai et al. 2009 indicates the K715N mutant exhibits decreased trafficking efficiency to the surface of Xenopus oocytes.
PP4
2yo female with congenital SNHL and EVA. Het. for this variant as well as c.1229C>T (p.Thr410Met), classified as Pathogenic by VCEP (LMM internal data, SCV000060131.6)
Not Met criteria codes
BS1
v2: Present in 0.09474% (29/30610) of South Asian chromosomes. v3: Present in 0.1312% (4/3048) of South Asian chromosomes. Using v2, BS1_P is not met because the filtering allele frequency is only 0.06777%.
BP4
REVEL score 0.352. Conserved in UCSC database (no mammals have Asn at this site). Splicing is not predicted to be impacted in Alamut.
Approved on: 2023-08-22
Published on: 2023-10-05
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.